Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Inhibition of tissue resident memory T-cells as a therapy for contact hypersensitivity

EF 2022-23

Résumé
Atopic dermatitis (AD) is a common and relapsing chronic allergic skin condition characterized by widespread red itchy skin, following exposure to airborne proteins. Current systemic medications for AD are excellent in treating active inflammation and improve symptoms, but AD inevitably returns. We do not yet have a cure. Interestingly, the hallmark of AD is that flares often localize to previously involved but healed skin. This observation has led to the concept of ‘‘local memory to allergens.’’ Recent studies have identified unique immune cells called tissue resident memory T-cells (Trm) as the culprit cells that persist for months in previous sites of allergic skin reactions and are important in chronic inflammation. Dysregulated Trm cells contribute to the recurrence of various skin diseases such as AD. A protein secreted by skin cells called interleukins (IL)-15 may contribute to the survival of Trm cells. Our project uses a novel mouse model of allergic skin disease to study the presence of Trm cells and the IL-15 protein in the skin. Additionally, we will block the IL-15 receptors that are expressed on Trm cells, using novel topical anti-inflammatory creams called tofacitinib and rapamycin. We will investigate the effectiveness of the creams by assessing how well they prevent inflammation even after multiple induction of skin allergic reactions. We hope that by blocking the IL-15 receptors, we can reduce the survival to Trm cells and as a result prevent flares of allergic skin reactions. The findings from this project will help us develop new medications to maintain long-term remission of various inflammatory skin diseases. In addition, the results of this project will have implications in other autoimmune diseases where Trm cells are known to be pathologic.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486351
Name
Khosravi-Hafshejani Touraj
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Inhibition of tissue resident memory T-cells as a therapy for contact hypersensitivity
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Animal Model Of Skin Inflammation; Atopic Dermatitis; Autoimmune Disease; Contact Hypersensitivity; Dermatology; Immunology; Inflammatory Skin Disease; T-Cells
Abstract
Atopic dermatitis (AD) is a common and relapsing chronic allergic skin condition characterized by widespread red itchy skin, following exposure to airborne proteins. Current systemic medications for AD are excellent in treating active inflammation and improve symptoms, but AD inevitably returns. We do not yet have a cure. Interestingly, the hallmark of AD is that flares often localize to previously involved but healed skin. This observation has led to the concept of ‘‘local memory to allergens.’’ Recent studies have identified unique immune cells called tissue resident memory T-cells (Trm) as the culprit cells that persist for months in previous sites of allergic skin reactions and are important in chronic inflammation. Dysregulated Trm cells contribute to the recurrence of various skin diseases such as AD. A protein secreted by skin cells called interleukins (IL)-15 may contribute to the survival of Trm cells. Our project uses a novel mouse model of allergic skin disease to study the presence of Trm cells and the IL-15 protein in the skin. Additionally, we will block the IL-15 receptors that are expressed on Trm cells, using novel topical anti-inflammatory creams called tofacitinib and rapamycin. We will investigate the effectiveness of the creams by assessing how well they prevent inflammation even after multiple induction of skin allergic reactions. We hope that by blocking the IL-15 receptors, we can reduce the survival to Trm cells and as a result prevent flares of allergic skin reactions. The findings from this project will help us develop new medications to maintain long-term remission of various inflammatory skin diseases. In addition, the results of this project will have implications in other autoimmune diseases where Trm cells are known to be pathologic.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Khosravi-Hafshejani, Touraj
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~